295 related articles for article (PubMed ID: 6300162)
1. 17 alpha-hydroxylase deficiency: mineralocorticoid hormone profiles in an affected family.
D'Armiento M; Reda G; Kater C; Shackleton CH; Biglieri EG
J Clin Endocrinol Metab; 1983 Apr; 56(4):697-701. PubMed ID: 6300162
[TBL] [Abstract][Full Text] [Related]
2. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
Pardini DP; Kater CE; Vieira JG; Biglieri EG
J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
[TBL] [Abstract][Full Text] [Related]
3. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia.
Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE
J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186
[TBL] [Abstract][Full Text] [Related]
4. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia.
Peterson RE; Imperato-McGinley J; Gautier T; Shackleton C
N Engl J Med; 1985 Nov; 313(19):1182-91. PubMed ID: 2932643
[TBL] [Abstract][Full Text] [Related]
5. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
Kater CE; Biglieri EG; Wajchenberg B
J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
[TBL] [Abstract][Full Text] [Related]
6. Distinctive plasma aldosterone, 18-hydroxycorticosterone, and 18-hydroxydeoxycorticosterone profile in the 21-, 17 alpha-, and 11 beta-hydroxylase deficiency types of congenital adrenal hyperplasia.
Kater CE; Biglieri EG
Am J Med; 1983 Jul; 75(1):43-8. PubMed ID: 6602548
[TBL] [Abstract][Full Text] [Related]
7. The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17 alpha-hydroxylase deficiency syndrome.
Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
J Clin Endocrinol Metab; 1982 Aug; 55(2):295-302. PubMed ID: 7045152
[No Abstract] [Full Text] [Related]
8. Adrenocorticotropin inhibition of mineralocorticoid hormone production.
Biglieri EG; Chang B; Hirai J; Brust N; Rost CR; Schambelan M
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():307s-311s. PubMed ID: 232023
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms establishing the mineralocorticoid hormone patterns in the 17 alpha-hydroxylase deficiency syndrome.
Biglieri EG
J Steroid Biochem; 1979 Jul; 11(1B):653-7. PubMed ID: 226795
[No Abstract] [Full Text] [Related]
10. Regulation of the mineralocorticoid hormones in adrenocortical disorders with adrenocorticotropin excess.
Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1749-58. PubMed ID: 6291814
[TBL] [Abstract][Full Text] [Related]
11. Combined 21- and 11 beta-hydroxylase deficiency in familial congenital adrenal hyperplasia.
Hurwitz A; Brautbar C; Milwidsky A; Vecsei P; Milewicz A; Navot D; Rösler A
J Clin Endocrinol Metab; 1985 Apr; 60(4):631-8. PubMed ID: 2982904
[TBL] [Abstract][Full Text] [Related]
12. The effect of ACTH stimulation on plasma steroids in two patients with congenital hypoaldosteronism and in their relatives.
Drop SL; Frohn-Mulder IM; Visser HK; Sippell WG; Dörr HG; Schöneshöfer M
Acta Endocrinol (Copenh); 1982 Feb; 99(2):245-50. PubMed ID: 6277129
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid response to low dose adrenocorticotropin infusion.
Tuck ML; Sowers JR; Asp ND; Viosca SP; Berg G; Mayes DM
J Clin Endocrinol Metab; 1981 Mar; 52(3):440-6. PubMed ID: 6257748
[TBL] [Abstract][Full Text] [Related]
14. The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia.
Kuhnle U; Chow D; Rapaport R; Pang S; Levine LS; New MI
J Clin Endocrinol Metab; 1981 Mar; 52(3):534-44. PubMed ID: 6257750
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
[TBL] [Abstract][Full Text] [Related]
16. Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia.
Pang S; Levine LS; Lorenzen F; Chow D; Pollack M; Dupont B; Genel M; New MI
J Clin Endocrinol Metab; 1980 Mar; 50(3):586-9. PubMed ID: 6244328
[TBL] [Abstract][Full Text] [Related]
17. Paper chromatographic systems for the separation of aldosterone, 18-hydroxycorticosterone, 18-hydroxydeoxycorticosterone, corticosterone and deoxycorticosterone.
Witzgall H; Hassan-Ali S
J Chromatogr; 1980 Sep; 198(1):70-5. PubMed ID: 7430313
[TBL] [Abstract][Full Text] [Related]
18. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
[TBL] [Abstract][Full Text] [Related]
19. A case of male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency and hormonal profiles in the nuclear family.
Rohmer V; Barbot N; Bertrand P; Nahoul K; Bigorgne JC; Forest MG
J Clin Endocrinol Metab; 1990 Aug; 71(2):523-9. PubMed ID: 2166072
[TBL] [Abstract][Full Text] [Related]
20. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
